课题基金 / 基金详情

Optimal Hydrophobicity of Lipoid Gene Delivery Agents

Optimal Hydrophobicity of Lipoid Gene Delivery Agents
类脂基因递送剂的最佳疏水性
批准号:
6932663
负责人:
ROBERT C MACDONALD
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-15 至 2007-05-31

项目摘要

项目成果

ROBERT C MACDONALD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cationic lipid-like compounds are commonly used in vitro and in vivo to deliver DNA to cells for the purposes of expressing exogenous genes. A number of clinical trials have indicated the promise of these agents for gene therapy, however lipid-based delivery remains less effective than the alternative viral vectors. Nevertheless, vast improvements have been made over the initial formulations and lipid-like agents have an important safety advantage over modified viruses. Avanti Lipids has been marketing an unusual category of cationic lipoids that are based on the natural lipid phosphatidylcholine and which, in vitro exhibit low cell toxicity. Through a simple chemical modification, the phosphatidyl cholines are converted to cationic compounds that form complexes with DNA and are effective transfection agents. These compounds, originally developed at Northwestern University, have recently been found to give very strong synergy in mixtures; for example, a mixture of 2 such compounds is much more effective than either compound separately. Furthermore, the optimal composition depends on conditions and cells. These findings point to an entirely new approach for enhancing gene (and probably drug) delivery, suggesting that the hydrophobic portions of these molecules maybe critical for the efficacy these cationic lipid-like agents. The aim of this proposal is to survey a variety of cationic phosphatidylcholines that have unusual hydrophobic moieties that would be difficult or impossible to synthesize in any other cationic lipoid class. The lipids will be synthesized by Avanti and tested for transfection activity and characterized with respect to relevant physical properties at Northwestern. Immediate commercialization is anticipated for compounds or mixtures with 50X higher activity than current compounds, although the expectation is that compounds with even higher activity will be discovered. All proposed methods have been previously published.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Modulation of a membrane lipid lamellar-nonlamellar phase transition by cationic lipids: a measure for transfection efficiency.
阳离子脂质对膜脂层状-非层状相变的调节:转染效率的衡量标准。
DOI: 10.1016/j.bbamem.2008.07.022
发表时间: 2008
期刊: Biochimica et biophysica acta
影响因子: --
作者: [Tenchov,BorisG, Wang,Li, Koynova,Rumiana, MacDonald,RobertC]
通讯作者: MacDonald,RobertC
Chicago State-Northwestern MS-PhD Bridge to the Future
  • 批准号:
    6683875
  • 项目类别:
  • 资助金额:
    $13.56万
  • 财政年份:
    2003
  • 负责人:
    ROBERT C MACDONALD
  • 依托单位:
Chicago State-Northwestern MS-PhD Bridge to the Future
  • 批准号:
    6931895
  • 项目类别:
  • 资助金额:
    $23.12万
  • 财政年份:
    2003
  • 负责人:
    ROBERT C MACDONALD
  • 依托单位:
Chicago State-Northwestern MS-PhD Bridge to the Future
  • 批准号:
    6792126
  • 项目类别:
  • 资助金额:
    $23.02万
  • 财政年份:
    2003
  • 负责人:
    ROBERT C MACDONALD
  • 依托单位:
ELECTROSTATICALLY MEDIATED MEMBRANE FUSION
  • 批准号:
    2761815
  • 项目类别:
  • 资助金额:
    $9.18万
  • 财政年份:
    1999
  • 负责人:
    ROBERT C MACDONALD
  • 依托单位:
海外基金